VASQUEZ NICKI (Chief Port. Strat & Alnce Ofcr) sold 48.8% of their position (12.19K shares) of SUTRO BIOPHARMA, INC. on the open market
Open‑market sale worth $60.9K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/31/2024ACC: 0001415889-24-002065
Officer· Chief Port. Strat & Alnce Ofcr
Since Aug 2021
-13.21K
Net shares
Net seller
$66.0K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
2.50K acquired · 15.71K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−12.19K
Price / share
$5.00
Trade value
$60.92K
% of position
48.8%
1/29/2024
24.99K→12.80K
Common Stock
Direct
Shares
+2.50K
Price / share
—
Trade value
—
% of position
19.5%
1/29/2024
12.80K→15.30K
Common Stock
Direct
Shares
−1.02K
Price / share
$4.99
Trade value
$5.11K
% of position
6.7%
1/29/2024
15.30K→14.28K
Total
Net shares
−10.71K
Net value
-$66.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/29/2024 | S · Sale | −12.19K | $5.00 | $60.92K | 48.8% | 24.99K | 12.80K |
| Common Stock Direct | 1/29/2024 | M · Option Exercise | +2.50K | — | — | 19.5% | 12.80K | 15.30K |
| Common Stock Direct | 1/29/2024 | F · Tax Withholding | −1.02K | $4.99 | $5.11K | 6.7% | 15.30K | 14.28K |
| Total | −10.71K | -$66.03K | ||||||
Derivative Transactions1
Restricted Stock Unit (RSU)
Direct
Converts to
Common Stock
2.50K shares
Shares
−2.50K
Strike price
Held after
0.00
Exercisable
—
1/29/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit (RSU) Direct | Common Stock2.50K shares | 1/29/2024 | M · Option Exercise | −2.50K | — | 0.00 |